توپيرامات تيڤع ٢٠٠ ملغ

Country: Iżrael

Lingwa: Għarbi

Sors: Ministry of Health

Ingredjent attiv:

TOPIRAMATE 200 MG

Disponibbli minn:

TEVA PHARMACEUTICAL INDUST.LTD

Kodiċi ATC:

N03AX11

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupp terapewtiku:

TOPIRAMATE

Indikazzjonijiet terapewtiċi:

Topiramate Teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome . Topiramate Teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.Topiramate Teva is indicated in adults for the prevention of migraines. The use of Topiramate Teva in the acute treatment of migraine has not been studied .

Data ta 'l-awtorizzazzjoni:

2011-08-01